Ascelia Pharma AB

Ascelia Pharma AB is a Swedish drug development company focused on identifying and commercializing novel treatments for rare cancer conditions. Headquartered in Malmö, Sweden. Here are key aspects of the company:

• Products & Services: Development and commercialization of novel drugs targeting unmet needs in rare cancer conditions; specifically developing Orviglance.
• Innovation & Technology: Filed a new patent application for Orviglance as of November 2025.
• Customers & Industries Served: People with rare cancer conditions. Ascelia Pharma AB is known for its vision to lead in addressing unmet medical needs through the development of novel oncology drugs.